Feasibility and potency of a IL-12-secreting multi-antigen dendritic cell vaccine in patients with leukemia and myeloma: a two-center trial

Antwerp University Hospital/Antwerp University
Hematology – Center for Cell Therapy and Regenerative Medicine
Wilrijkstraat 10               
2650   Edegem

Toegekend bedrag: € 248 000, verdeeld over 2 jaar

University of Liège
Department  of Hematology
CHU Sart Tilman B35
4000  Liège